[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Start August 2017 with “Biosimilar from Development to Registration” Seminar!

06 Jul 2017 • by Natalie Aster

LONDON – Organised by NetZealous, the unique seminar “Biosimilar from Development to Registration” comes to Morrisville (NC, the USA) on August 3-4, 2017. Courtyard Raleigh-Durham Airport was chosen as a venue for the forthcoming Event.

The organiser of Biosimilar from Development to Registration, NetZealous LLC DBA GlobalCompliancePanel, is more than happy to invite all the interested audience to take part in this outstanding Seminar to delve deep into the biosimilars market and to discuss all the important associated regulatory, technical and quality issues vital to secure successful performance in the market.

Major Issues on Agenda Include:

  • Design and TPP
  • Pre-clinical testing and comparability
  • Clinical testing
  • Analytical studies
  • Stability of biosimilar products
  • etc.

This Seminar will be highly useful and beneficial for Regulatory Affairs representatives, Medical Officers, Clinical Trial Managers, amid others. The Seminar will provide all the participants with brief but all-encompassing profound insight into the regulatory guideline required for market access.

Would you like to expand your knowledge of the biosimilars market? Do you want to become abreast of the major legislative issues and key requirements in this field? Are you interested in expanding your business and increasing presence of your products in the market? If “yes”, take time by the forelock and apply for participation in Biosimilar from Development to Registration” seminar right now!

Market Publishers reminds that only a month left to this outstanding Seminar. Remember that you will be eligible for a discount if you register 5+ attendees.

For further details on the Event do not hesitate to contact our Sales Manager, Alison, by e-mail [email protected] or tel. +44 20 8123 2220. 


The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970
[email protected]

Analytics & News

Weekly Digest